Neural stem cells (NSCs) possess high potencies of self-renewal and neuronal
differentiation. We explored here whether transplantation of human NSCs cloned by v-myc …

Parkinson disease is a neurodegenerative disease characterized by loss of midbrain
dopaminergic neurons resulting in movement disorder. Neural stem cells (NSC) of the CNS …

Stimulation of endogenous repair in neurodegenerative diseases, such as Parkinson's
disease (PD), appears to be a novel and promising therapeutic application of stem cells …

Although cell transplantation can rescue motor defects in Parkinson's disease (PD) models,
whether and how grafts functionally repair damaged neural circuitry in the adult brain is not …

It is thought that the ability of human mesenchymal stem cells (hMSC) to deliver neurotrophic
factors might be potentially useful for the treatment of neurodegenerative disorders. The aim …

Human embryonic stem cells (hESCs) may potentially serve as a renewable source of cells
for transplantation. In Parkinson's disease, hESC‐derived dopaminergic (DA) neurons may …

The ability to differentiate neural stem cells (NSCs) into dopamine neurons is fundamental to
their role in cell replacement therapies for neurodegenerative disorders such as Parkinson's …

Cell replacement is currently being explored as a therapeutic approach for
neurodegenerative disease. Using stem cells as a source, transplantable progenitors can …

Stem cell transplantation is a promising tool for the treatment of neurodegenerative
disorders, including Parkinson's disease (PD); however, the therapeutic routes and …

Bone marrow-derived human mesenchymal stem cells (hMSCs) have shown promise in in
vitro neuronal differentiation and in cellular therapy for neurodegenerative disorders …